NASDAQ:MEDS TRxADE HEALTH (MEDS) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free MEDS Stock Alerts $6.29 +0.28 (+4.66%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$6.09▼$6.4250-Day Range$5.96▼$33.9052-Week Range$3.69▼$44.56Volume11,754 shsAverage Volume26,945 shsMarket Capitalization$8.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get TRxADE HEALTH alerts: Email Address Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here About TRxADE HEALTH Stock (NASDAQ:MEDS)TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.Read More MEDS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MEDS Stock News HeadlinesMay 3, 2024 | forbes.comBest Prostate Health Supplements Of 2024, According To ExpertsApril 30, 2024 | msn.comWeight loss drugs like Wegovy have taken the country by storm. But who can afford them?May 5, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...April 28, 2024 | msn.comSemaglutide v. tirzepatide: What to know about popular weight loss and diabetes drugs like OzempicApril 27, 2024 | msn.comDEA wants your unused prescription medicationsApril 26, 2024 | msn.comDrug Take Back Day gives East Tennesseans the chance to dispose of unwanted prescription drugsApril 23, 2024 | globenewswire.comTRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KApril 18, 2024 | msn.comLexington among cities with highest cost of prescription medications, study showsMay 5, 2024 | Paradigm Press (Ad)Never use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...April 17, 2024 | msn.comWhat Medications Can Cause Antiphospholipid Syndrome? A Review By DoctorsApril 17, 2024 | msn.comOn Your Side: Know this about flea and tick medicationsApril 11, 2024 | msn.comThis multifunctional system can send drugs where they can be effective in body’s tissues, organsApril 11, 2024 | msn.comHundreds of drugs are in short supply around the U.S., pharmacists warnApril 1, 2024 | msn.comZenCortex Review: 180 Days Evaluation – Does This Ear Health Supplement Really Work?March 31, 2024 | msn.comThese Common Medications Could Have Terrifying Side EffectsMarch 29, 2024 | msn.comMedicare increase in spending on diabetes drugs could cost seniors more moneyMarch 29, 2024 | msn.comPopular Medications That Can Make Your Muscles WeakMarch 12, 2024 | msn.comFAIR Meds Act could impact costs for prescriptionsMarch 12, 2024 | msn.comA massive cyberattack has some Arizona health providers reeling. Here's what we knowMarch 11, 2024 | msn.comTexas health centers awarded over $19 million in grantsMarch 11, 2024 | msn.comLexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare moversMarch 6, 2024 | msn.comCrude Oil Rises Sharply; Foot Locker Shares PlungeMarch 6, 2024 | msn.comTRxADE Health Stock Skyrockets: Here's WhyMarch 6, 2024 | globenewswire.comTRxADE Health, Inc. Announces Special Cash DividendFebruary 20, 2024 | msn.comNew model identifies drugs that shouldn’t be taken togetherFebruary 20, 2024 | seekingalpha.comGCT, VHC and IPWR among mid-day moversFebruary 20, 2024 | msn.comTRxADE HEALTH Rises Over 140% - What's Going On?See More Headlines Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/24/2021Dividend Payable3/22/2024Ex-Dividend for 3/22 Dividend3/25/2024Today5/05/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryN/A Current SymbolNASDAQ:MEDS CUSIPN/A CIK1382574 Webwww.trxade.com Phone(800) 261-0281Fax800-265-6932Employees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($6.9388) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,840,000.00 Net Margins-215.72% Pretax Margin-165.87% Return on Equity-428.28% Return on Assets-116.96% Debt Debt-to-Equity Ratio0.05 Current Ratio0.24 Quick Ratio0.24 Sales & Book Value Annual Sales$8.27 million Price / Sales1.07 Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book13.98Miscellaneous Outstanding Shares1,410,000Free Float725,000Market Cap$8.87 million OptionableNot Optionable Beta2.14 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)Founder, Chairman, CEO & Secretary Comp: $354.23kMr. Prashant Patel R.Ph. (Age 50)Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director Comp: $147.04kDr. Ramesh KenchappaChief Scientific OfficerMr. David M. Saslow Esq.Inhouse CounselDr. Shafaat Pirani Pharm.D.Executive Vice President of Alliance Pharma Solutions, LLCKey CompetitorsCosmos HealthNASDAQ:COSMBIMINASDAQ:BIMIeFFECTOR TherapeuticsNASDAQ:EFTRNuCanaNASDAQ:NCNAPrecipioNASDAQ:PRPOView All Competitors MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed in 2024? TRxADE HEALTH's stock was trading at $5.20 on January 1st, 2024. Since then, MEDS stock has increased by 21.0% and is now trading at $6.29. View the best growth stocks for 2024 here. Are investors shorting TRxADE HEALTH? TRxADE HEALTH saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 20,500 shares, a drop of 39.7% from the March 31st total of 34,000 shares. Based on an average daily volume of 422,000 shares, the short-interest ratio is currently 0.0 days. Approximately 2.4% of the shares of the company are sold short. View TRxADE HEALTH's Short Interest. When is TRxADE HEALTH's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our MEDS earnings forecast. How were TRxADE HEALTH's earnings last quarter? TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its quarterly earnings results on Sunday, October, 24th. The company reported ($2.40) earnings per share for the quarter, missing the consensus estimate of ($1.95) by $0.45. The company had revenue of $2.55 million for the quarter, compared to analysts' expectations of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 428.28% and a negative net margin of 215.72%. During the same quarter in the previous year, the business posted $0.30 earnings per share. How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH? TRxADE HEALTH announced a dividend on Wednesday, February 28th. Shareholders of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date of this dividend is Monday, March 25th. Read our dividend analysis for MEDS. When did TRxADE HEALTH's stock split? TRxADE HEALTH shares reverse split on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of TRxADE HEALTH own? Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN). How do I buy shares of TRxADE HEALTH? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MEDS) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
